Evidence map›Paper›PMID 31463529›Full record

ArticleInternational urogynecology journal2020

Patient navigation for overactive bladder improves access to care.

Matthew Rohloff, Gregg Peifer, Jannah H Thompson

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Health Disparities and Overactive Bladder: Bridging the Gap.Current bladder dysfunction reports · 2026
    Review
  5. Article
  6. Implementing telemedicine in urogynecology: A feasibility study.International urogynecology journal · 2023
    Observational
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew RohloffMetro Health Hospital: University of Michigan Health Department of Urological Surgery, 5900 Byron Center Avenue, Wyoming, MI, 49519, USA. Matthew.Rohloff@metrogr.org.ORCID 0000-0003-4182-0374
Gregg PeiferMetro Health Hospital: University of Michigan Health Department of Urological Surgery, 5900 Byron Center Avenue, Wyoming, MI, 49519, USA.
Jannah H ThompsonMetro Health Hospital: University of Michigan Health Department of Urological Surgery, 5900 Byron Center Avenue, Wyoming, MI, 49519, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisPatients with overactive bladder (OAB) become discouraged with medication therapy because of the side effects, minimal subjective improvement and costs of therapy. With the implementation of a patient navigation pathway there is increased communication, subsequently leading to increased patient retention rates and utilization of third-line therapies.

methodsThis was a quality improvement study carried out over a 17-month period comparing utilization of a navigation pathway versus patients without navigation. The data were obtained using an online database (PPS Analytics) to compare medication use, cystoscopy, urodynamic studies, use of third-line therapy, and return visits.

resultsA total of 535 patients were included in the analysis and broken down into two respective groups. Group 1 were those placed on the navigation pathway and able to be reached via telephone (n = 431). Group 2 were those started on the navigation pathway who were not able to be reached via telephone, but were chart reviewed by a navigator (n = 104). Third-line therapy usage for groups 1 and 2 was 24% and 11% respectively. Return visits for additional OAB management for groups 1 and 2 were found to be 71% and 50% respectively.

conclusionPatient retention levels and utilization of third-line therapies are significantly improved when utilizing a navigation pathway. With 24% of the patients included in this study opting for third-line therapy, this represents a 600% increase in third-line therapies over national averages.

Indexed as

Patient NavigationUrinary Bladder, OveractiveHealth Services AccessibilityHumansCare pathwayOveractive bladderPatient navigation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.